| 1 |
BTK
| [7] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | D10223
D10223
|
Ibrutinib
| [3] 28 28, 60, 61 |
| 2 |
BTK
| [7] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | D10893
D10893
|
Acalabrutinib
| [2] 46 46, 61 |
| 3 |
BTK
| [7] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | D11422
D11422
|
Zanubrutinib
| [2] 300 300, 331 |
| 4 |
BTK
| [7] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | D11457
D11457
|
Fenebrutinib
| [1] 13 13 |
| 5 |
BTK
| [7] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | D11478
D11478
|
Branebrutinib
| [3] 46 46, 49, 53 |
| 6 |
BTK
| [7] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | D12160
D12160
|
Orelabrutinib
| [3] 13 13, 61, 63 |